
Vizz (LENZ Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.

Vizz (LENZ Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.

In this podcast, Marjan Farid, MD; Beeran Meghpara, MD; and John Hovanesian, MD; review the role of neuromodulation in the pathogenesis of dry eye disease (DED). Additionally, the expert panel discusses a case study of a typical patient presenting with DED and reviews current and newly available treatment options.

EyePoint Pharmaceuticals completes enrollment for the LUCIA trial, advancing DURAVYU's potential as a new treatment for wet AMD.

The expanded clinical suite at Stanton Optical will include keratography, optical coherence tomography, and personalized therapy options for patients with dry eye.

Paul Levine, OD, FAAO, FIAOMC, details a pediatric case of high myopia in which the patient's prescription had increased from –5.75 DS OU to OD –7.00 DS, OS –6.75 DS within a year.

The first-in-class, twice-daily topical formulation is intended for the treatment of nonproliferative diabetic retinopathy and diabetic macular edema.

A total of $7000 in scholarships was awarded to 3 optometry students as part of the National Optometric Student Association (NOSA) scholarship program.

The study's primary objective was to demonstrate that LUMIFY Preservative Free redness reliever eye drops are noninferior to LUMIFY redness reliever eye drops in reducing ocular redness.

The module can be used in combination with Ziemer’s FEMTO LDV Z8 femtosecond laser platform, an all-in-one laser for refractive, cataract, and therapeutic surgery.

Gyrate atrophy of the choroid and retina is a form of choroidal sclerosis and is a rare, progressive, autosomal recessive, inherited genetic disease that primarily affects the ocular tissue.

The company was presented with the PRMA President’s Award, Platinum Recycling Award, and recognitions in Leadership in Environmental Performance.

What we should be telling our patients about the remission of type 2 diabetes with weight loss.

Catch up on the top stories in optometry during the week of July 21-July 25.

The enhanced clarity in the lens helps reduce glare and enhance visual comfort, according to the company.

The campaign provides tools to patients, researchers, clinicians, industry, and advocates with tools to tell their stories that advocate for vision research.

The tool is designed to help with the application of mono-dose, dry eye eye drop vials more easily and accurately.

The solution missed the primary end point of the trial, which was complete resolution of debris after 6 weeks of twice-daily dosing.

The EyeSouth affiliate network now includes more than 320 doctors providing medical and surgical eye care services at over 235 locations.

Santen introduces low-dose atropine in Germany, marking a significant advancement in myopia management for children amid a global epidemic.

This will be the Flying Eye Hospital’s first visit to Rwanda.

Survey participants cited cost concerns, perceived inevitability, and deprioritization as obstacles to receiving eye care.

New research reveals collagen mimetic peptides may effectively restore ocular tissue stiffness, offering hope for myopia and other eye diseases.

Ophthalmologists report high satisfaction with lifitegrast for dry eye treatment, noting rapid symptom relief and effective management in diverse patient populations.

The bill will make 3 changes that enhance oral medication usage, with 1 change expanding access to in-office procedures.

Catch up on the top stories in optometry during the week of July 14-July 18.

Nicox’s nitric oxide (NO)-donating bimatoprost eye drop works to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.

Study authors Preeya K. Gupta, MD; and Paul Karpecki, OD, formulated a case in their literature review for the routine evaluation of the upper eyelid during meibomian gland imaging.

ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.

A Prescription Drug User Fee Act (PDUFA) target action date of December 16, 2025, was assigned by the FDA.

These screening solutions will work to make early detection of diabetic retinopathy easier with on-the-spot screening.